Key presentations include:<\/b><\/p>\n \n\u201cOur data at ASH 2025 raises the bar for patient and physician expectations of what\u2019s possible. Our long-term data drives confidence in duration of response in CLL treatment decisions,\u201d said Lai Wang, Ph.D., Global Head of R&D at BeOne. \u201cSix-year SEQUOIA and long-term extension data from patients originally enrolled in ALPINE cement BRUKINSA\u2019s role as the backbone of CLL therapy, and our three innovative B-cell treatment modalities of BTK inhibition, BCL2 inhibition, and BTK degradation have the potential to advance options that evolve with patient needs across all stages of disease.\u201d<\/p>\n Additional highlights include:<\/b><\/p>\n \nNever-before-presented clinical data from BeOne\u2019s emerging pipeline will also be shared at the meeting, including in new combinations and disease areas.<\/p>\n \nOngoing clinical data from BRUKINSA <\/b>continue to demonstrate clinically meaningful benefit for patients with CLL\/SLL.<\/p>\n \nPresentations also include data leveraging real-world evidence and validated modeling approaches to refine understanding of real-world experience and outcomes achieved with covalent BTK inhibitors.<\/p>\n \n\u201cIn CLL, selecting the right therapy for the right patient at the right time is essential, and continuous treatment with BTK inhibitors like BRUKINSA has become central to achieving enduring disease control,\u201d said Dany Habr, M.D., Senior Vice President and Head of Medical Affairs, North America & International Markets at BeOne. \u201cEmerging data from real-world settings suggest that BRUKINSA may offer a more manageable side effect profile, including for symptoms such as fatigue, pain, headache \u2013 further supporting its role as the BTKi of choice.\u201d<\/p>\n BeOne Presentations at ASH 2025 (organized chronologically by asset)<\/b><\/p>\n BRUKINSA: The backbone of the hematology franchise<\/b><\/p>\n\n
\n
\n
\n
\n
\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20251120303213\/en\/2494825\/3\/BGI2404_BeOne_Primary_Logo_RGB_M04_V01.jpg\"){kind=logo}
<\/td>\n<\/tr>\n